Effect of reversal of neuromuscular blockade with sugammadex versus usual care on bleeding risk in a randomized study of surgical patients

Anesthesiology

Volumn 121, Issue 5, 2014, Pages 969-977

  Rahe Meyer, Niels ^a   Fennema, Hein ^b   Schulman, Sam ^c   Klimscha, Walter ^d   Przemeck, Michael ^e   Blobner, Manfred ^f   Wulf, Hinnerk ^g   Speek, Marcel ^b   Sisk, Christine McCrary ^h   Williams Herman, Debora ^h   Woo, Tiffany ^h   Szegedi, Armin ^h  

^a FRANZISKUS HOSPITAL   (Germany)

^b Biostatistics MSD Oss   (Netherlands)

^c MCMASTER UNIVERSITY   (Canada)

^d DANUBE HOSPITAL   (Austria)

^e Department of Anesthesia and Intensive Care ^*  (Germany)

^f TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^g UNIVERSITY HOSPITAL MARBURG   (Germany)

^h MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIVITAMIN K; ATROPINE; GLYCOPYRRONIUM BROMIDE; HEMOGLOBIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; NEOSTIGMINE; ROCURONIUM; SUGAMMADEX; VECURONIUM; FIBRINOLYTIC AGENT; GAMMA CYCLODEXTRIN DERIVATIVE;

ADULT; AGED; ANEMIA; ANESTHETIC RECOVERY; ARTICLE; BLOOD TRANSFUSION; CONSTIPATION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG SAFETY; FEMALE; HEMATOMA; HEMOGLOBIN BLOOD LEVEL; HIP FRACTURE; HUMAN; KIDNEY FUNCTION; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; NEUROMUSCULAR BLOCKADE REVERSAL; NEUROMUSCULAR BLOCKING; OSTEOSYNTHESIS; PAIN; PARTIAL THROMBOPLASTIN TIME; PHARMACOLOGICAL PROCEDURES; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE THROMBOSIS; PROTHROMBIN TIME; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SLEEP DISORDER; SURGICAL PATIENT; SURGICAL RISK; THROMBOSIS PREVENTION; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT; VENOUS THROMBOEMBOLISM; VOMITING; ADOLESCENT; BIOASSAY; BLOOD CLOTTING; COMPARATIVE STUDY; DRUG EFFECTS; MIDDLE AGED; MORTALITY; OPERATIVE BLOOD LOSS; THROMBOSIS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANESTHESIA RECOVERY PERIOD; BLOOD COAGULATION; BLOOD LOSS, SURGICAL; DOUBLE-BLIND METHOD; ENDPOINT DETERMINATION; FEMALE; FIBRINOLYTIC AGENTS; GAMMA-CYCLODEXTRINS; HUMANS; MALE; MIDDLE AGED; NEUROMUSCULAR BLOCKADE; THROMBOSIS; YOUNG ADULT;

EID: 84914166120     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0000000000000424     Document Type: Article

References (17)

1. Bom A, Bradley M, Cameron K, Clark JK, Van Egmond J, Feilden H, MacLean EJ, Muir AW, Palin R, Rees DC, Zhang MQ: A novel concept of reversing neuromuscular block: Chemical encapsulation of rocuronium bromide by a cyclodextrin- based synthetic host. Angew Chem Int Ed Engl 2002; 41:266-70
2. Epemolu O, Bom A, Hope F, Mason R: Reversal of neuromuscular blockade and simultaneous increase in plasma rocuronium concentration after the intravenous infusion of the novel reversal agent Org 25969. Anes thesiolo gy 2003; 99:632-7; discussion 6A
3. G roudine SB, Soto R, Lien C, Drover D, Roberts K: A randomized, dose-finding, phase II study of the selective relaxant binding drug, Sugammadex, capable of safely reversing profound rocuronium-induced neuromuscular block. Anesth Analg 2007; 104:555-62
4. Shields M, Giovannelli M, Mirakhur RK, Moppett I, Adams J, Hermens Y: Org 25969 (sugammadex), a selective relaxant binding agent for antagonism of prolonged rocuroniuminduced neuromuscular block. Br J Anaesth 2006; 96:36-43
5. Sorgenfrei IF, Norrild K, Larsen PB, Stensballe J, Ostergaard D, Prins ME, Viby-Mogensen J: Reversal of rocuroniuminduced neuromuscular block by the selective relaxant binding agent sugammadex: A dose-finding and safety study. Anes thesiolo gy 2006; 104:667-74
6. Sparr HJ, Vermeyen KM, Beaufort AM, Rietbergen H, Proost JH, Saldien V, Velik-Salchner C, Wierda JM: Early reversal of profound rocuronium-induced neuromuscular blockade by sugammadex in a randomized multicenter study: Efficacy, safety, and pharmacokinetics. Anes thesiolo gy 2007; 106:935-43
7. Suy K, Morias K, Cammu G, Hans P, van Duijnhoven WG, Heeringa M, Demeyer I: Effective reversal of moderate rocuronium- or vecuronium-induced neuromuscular block with sugammadex, a selective relaxant binding agent. Anes thesiolo gy 2007; 106:283-8
8. Vanacker BF, Vermeyen KM, Struys MM, Rietbergen H, Vandermeersch E, Saldien V, Kalmar AF, Prins ME: Reversal of rocuronium-induced neuromuscular block with the novel drug sugammadex is equally effective under maintenance anesthesia with propofol or sevoflurane. Anesth Analg 2007; 104:563-8
9. Sacan O, White PF, Tufanogullari B, Klein K: Sugammadex reversal of rocuronium-induced neuromuscular blockade: A comparison with neostigmine-glycopyrrolate and edrophonium- atropine. Anesth Analg 2007; 104:569-74
10. de Kam PJ, El Galta R, Kruithof AC, Fennema H, van Lierop MJ, Mihara K, Burggraaf J, Moerland M, Peeters P, Troyer MD: No clinically relevant interaction between sugammadex and aspirin on platelet aggregation and coagulation parameters. Int J Clin Pharmacol Ther 2013; 51:976-85
11. De Kam PJ, Grobara P, Prohn M, Höppener F, Kluft C, Burggraaf J, Langdon RB, Peeters P: Effects of sugammadex on activated partial thromboplastin time and prothrombin time in healthy subjects. Int J Clin Pharmacol Ther 2014; 52:227-36
12. Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16:31-41
13. Schulman S, Angerås U, Bergqvist D, Eriksson B, Lassen MR, Fisher W; Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis: Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients. J Thromb Haemost 2010; 8:202-4
14. Sampson HA, Muñoz-Furlong A, Campbell RL, Adkinson NF Jr, Bock SA, Branum A, Brown SG, Camargo CA Jr, Cydulka R, Galli SJ, Gidudu J, Gruchalla RS, Harlor AD Jr, Hepner DL, Lewis LM, Lieberman PL, Metcalfe DD, O'Connor R, Muraro A, Rudman A, Schmitt C, Scherrer D, Simons FE, Thomas S, Wood JP, Decker WW: Second symposium on the definition and management of anaphylaxis: Summary report-Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol 2006; 117:391-7
15. Johanson NA, Lachiewicz PF, Lieberman JR, Lotke PA, Parvizi J, Pellegrini V, Stringer TA, Tornetta P III, Haralson RH III, Watters WC III: Prevention of symptomatic pulmonary embolism in patients undergoing total hip or knee arthroplasty. J Am Acad Orthop Surg 2009; 17:183-96
16. European Medicines Agency. Assessment Report for Bridion. Document Reference EMEA/CHMP/317523/2008. 2008.
17. Raft J, Betala Belinga JF, Jurkolow G, Desandes E, Longrois D, Meistelman C: Évaluation clinique du saignement postchirurgical après injection de sugammadex. Ann Fr Anesth Reanim 2011; 30:714-7